Xin Lang Cai Jing·2025-11-13 01:37Core Viewpoint - Spring Medical experienced a 3.36% increase in stock price on November 12, with a trading volume of 99.78 million yuan, indicating strong market interest [1] Financing Summary - On November 12, Spring Medical had a financing buy-in amount of 10.89 million yuan and a financing repayment of 12.84 million yuan, resulting in a net financing buy of -1.95 million yuan [1] - As of November 12, the total financing and securities lending balance for Spring Medical was 55.28 million yuan, which accounts for 0.68% of its market capitalization, indicating a high financing balance compared to the past year [1] - The financing balance has exceeded the 90th percentile level over the past year, suggesting elevated investor activity [1] Company Overview - Beijing Spring Medical Co., Ltd. specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company was established on February 12, 1998, and went public on December 30, 2021 [2] - As of September 30, 2025, Spring Medical reported a revenue of 755.6 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, reflecting a significant increase of 213.21% [2] Dividend and Shareholder Information - Since its A-share listing, Spring Medical has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2][3] - Notable institutional shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed Fund, both of which are new entrants among the top ten circulating shareholders [3]